Pendal Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,615
| Closed | -$465K | – | 458 |
|
|
2022
Q2 | $465K | Buy |
+5,615
| New | +$465K | ﹤0.01% | 360 |
|
|
2019
Q4 | – | Sell |
-11,429
| Closed | -$770K | – | 447 |
|
|
2019
Q3 | $770K | Sell |
11,429
-921
| -7% | -$62.1K | 0.01% | 317 |
|
|
2019
Q2 | $1.06M | Buy |
12,350
+622
| +5% | +$53.3K | 0.01% | 272 |
|
|
2019
Q1 | $1.04M | Hold |
11,728
| – | – | 0.01% | 289 |
|
|
2018
Q4 | $999K | Sell |
11,728
-5
| -0% | -$426 | 0.02% | 267 |
|
|
2018
Q3 | $1.14M | Hold |
11,733
| – | – | 0.02% | 281 |
|
|
2018
Q2 | $1.11M | Sell |
11,733
-13
| -0.1% | -$1.23K | 0.01% | 291 |
|
|
2018
Q1 | $952K | Buy |
11,746
+161
| +1% | +$13.1K | 0.01% | 327 |
|
|
2017
Q4 | $1.03M | Buy |
11,585
+512
| +5% | +$45.7K | 0.01% | 296 |
|
|
2017
Q3 | $1.03M | Buy |
11,073
+4,463
| +68% | +$415K | 0.01% | 303 |
|
|
2017
Q2 | $600K | Buy |
+6,610
| New | +$600K | 0.01% | 346 |
|